Kyle Blankenship – Page 17 – Endpoints News

about the author

Kyle Blankenship

kyle@endpointsnews.com @ka_blankenship

Kyle Blankenship on LinkedIn

author articles

Eli Lilly's IL-23 inhibitor mirikizumab shows late-stage promise in ulcerative colitis — but AbbVie's Skyrizi looms

5 years ago

Vivek Ramaswamy's LNP delivery tech play Genevant scores $600M licensing deal from Takeda for nucleic acid therapies

5 years ago

Backed by Indian biosim giant Biocon, bispecifics player Bicara debuts with $40M and solid tumors on the radar

5 years ago

ElevateBio adds another $525M to its war chest as it looks to build on next-gen manufacturing 'basecamp'

5 years ago

With hopes for antibodies waning, the NIH will test Novartis partner's novel antiviral in hospitalized Covid-19 ...

5 years ago

Albert Bourla bagged $21M in year marked by generics spinoff, colossal R&D effort for Covid-19 vaccine

5 years ago

Monte Rosa pulls in $95M to test its 'molecular glues,' and the first target is GSPT1

5 years ago

Ani Pharma picks up generic player for a cool $210M, turbocharging its manufacturing and R&D wings

5 years ago

Alex Gorsky earned a whopping $29.6M in 2020 as drugmaker pivoted around Covid-19 vaccine R&D

5 years ago

Recall report: BRP Pharma pulls 47 bottles of generic diuretic spironolactone after mixing different strength pills

5 years ago

Synthetic DNA player Touchlight scores $60M round to more than triple manufacturing capacity as mRNA gets hot

5 years ago

Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up

5 years ago

Innovation in the clinic is picking up steam. How adaptive designs could pave the road to personalized medicine

5 years ago

Exclusive: Ready to exit 'quiet mode,' joint entity Ventyx debuts its immune modulator pipeline with $114M round

5 years ago

Mount Sinai leasing office space for outpatient clinics, biotech research; Zolgensma OK to be sold in UK, NICE says

5 years ago

Gilead's Biktarvy build its case for long-term use with 4-year data showing lasting HIV suppression

5 years ago

AbbVie offloads UK site for $119M in sale to Chinese cell and gene therapy player Pharmaron

5 years ago

Galapagos posts a safety win for filgotinib, but is it too little, too late?; Bio-Techne inks $320M molecular ...

5 years ago

Novartis pairs up with CureVac to help drive Covid-19 shot production but may miss the show in the US, EU

5 years ago

With $117M in fresh cash, Amunix paves path to the clinic for 'universal mask' prodrug on the hunt for HER2 tumors

5 years ago

GSK, Vir's hopes for a Covid-19 antibody fall flat in NIH 'master protocol' with no benefit in hospitalized patients

5 years ago

Swiss CDMO Celonic finds a home at Novartis' Stein hub, plans to add 250 new jobs centered on next-gen drugs

5 years ago

After bailing on Covid-19 vaccines, Merck will team up with J&J to produce its shot as part of unusual Big Pharma ...

5 years ago

Merck pulls Keytruda in SCLC after accelerated nod. Is the FDA getting tough on drugmakers that don't hit their ...

5 years ago

First page Previous page 14 15 161718 19 20 Next page Last page